Dipna Pharmachem Ltd
DPLDipna Pharmachem Ltd
DPL
Health CarePharmaceuticals
SmallcapWith a market cap of ₹17 cr, stock is ranked 4,250
High RiskStock is 4.46x as volatile as Nifty
7.464.04% (+0.29)
7.464.04% (+0.29)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 0.46 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.92 | 6.65 | 0.51% |
Forecast & Ratings
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Dipna Pharmachem Limited trades and imports pharmaceutical raw materials and active ingredients, assisting in contract manufacturing compliance.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
PE Ratio
45.12
1Y Return
47.98%
Buy Reco %
80.00
Cipla Ltd
PE Ratio
28.85
1Y Return
21.87%
Buy Reco %
70.97
Torrent Pharmaceuticals Ltd
PE Ratio
69.10
1Y Return
57.51%
Buy Reco %
74.07
Mankind Pharma Ltd
PE Ratio
58.77
1Y Return
53.54%
Buy Reco %
80.00
Dr Reddy's Laboratories Ltd
PE Ratio
19.05
1Y Return
18.80%
Buy Reco %
37.50
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
| Financial Year | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 16.57 | 20.19 | 30.55 | 31.02 | 72.77 | 99.94 | 164.34 | — | ||||||||
Raw Materials | 17.08 | 17.52 | 31.16 | 31.22 | 67.67 | 108.13 | 176.35 | — | ||||||||
| Power & Fuel Cost | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |||||||||
| Employee Cost | 0.00 | 0.00 | 0.38 | 0.41 | 0.00 | 0.00 | 0.00 | |||||||||
| Selling & Administrative Expenses | 0.70 | 0.63 | 0.61 | 0.54 | 1.66 | 1.92 | 2.77 | |||||||||
| Operating & Other expenses | -1.62 | 1.53 | -2.07 | -1.57 | 1.25 | -12.48 | -18.24 | |||||||||
EBITDA | 0.40 | 0.50 | 0.47 | 0.42 | 2.19 | 2.37 | 3.45 | — | ||||||||
| Depreciation/Amortization | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | — | ||||||||
| PBIT | 0.40 | 0.49 | 0.46 | 0.41 | 2.18 | 2.36 | 3.43 | — | ||||||||
| Interest & Other Items | 0.33 | 0.43 | 0.39 | 0.35 | 0.61 | 0.97 | 2.01 | — | ||||||||
| PBT | 0.07 | 0.06 | 0.07 | 0.06 | 1.57 | 1.39 | 1.42 | — | ||||||||
| Taxes & Other Items | 0.01 | 0.02 | 0.00 | 0.03 | 0.41 | 0.47 | 0.34 | — | ||||||||
| Net Income | 0.06 | 0.04 | 0.07 | 0.03 | 1.16 | 0.92 | 1.08 | — | ||||||||
| EPS | 2.93 | 1.96 | 3.42 | 1.47 | 56.74 | 1.25 | 0.56 | — | ||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Company Updates
Peers & Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Dipna Pharmachem Ltd | 16.14 | 0.46 | — |
| Sun Pharmaceutical Industries Ltd | 45.12 | 6.44 | 0.75% |
| Cipla Ltd | 28.85 | 4.44 | 0.88% |
| Torrent Pharmaceuticals Ltd | 69.10 | 16.69 | 0.83% |
Price Comparison
Compare DPL with any stock or ETFCompare DPL with any stock or ETF
DPL
Shareholdings
Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Sep 2024
Shareholding History
Foreign Institutions
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
DPL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNews & Opinions
Articles & Videos
Corporate
Dipna Pharmachem announces board meeting date
Dipna Pharmachem will hold a meeting of the Board of Directors of the Company on 29 July 2024.Powered by Capital Market - Live
4 months agoCapital Market - Live
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 52.1%, vs industry avg of 9.03%
Increasing Market Share
Over the last 5 years, market share increased from 0.01% to 0.04%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 93.32%, vs industry avg of 15.27%